The medical community needs a better understanding of people suffering from severe brain injuries, a Weill Cornell Medicine medical ethicist argues in his new book.
Dr. Alvin Mushlin wins the 2015 Career Achievement Award from Society for Medical Decision Making and other awards, honors, prizes and achievements for the week of Oct. 9 - Oct. 16.
Weill Cornell Medicine has received more than $10 million from the National Institutes of Health to study the effects of substances of abuse on the developing brain.
Healthcare providers have the unique power and responsibility to discourage the use of e-cigarettes among teenagers, and should discuss the products when they counsel adolescent patients about substance abuse.
In a new commentary, Dr. Mark Lachs advocates framing age-associated financial vulnerability as a possible clinical syndrome that warrants research, protective public policies and heightened awareness among physicians.
Meet the Weill Cornell alumni who lead the Clinical Center at the National Institutes of Health in Bethesda, Md., where a nurse with Ebola was treated.
After two decades of growth that has transformed Weill Cornell Medical College into a global healthcare leader, the institution reveals a new name -- Weill Cornell Medicine -- which more comprehensively captures the full scope of its mission.
Dr. Leonard Girardi has been named chair of the Department of Cardiothoracic Surgery at Weill Cornell Medical College and cardiothoracic surgeon-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center
A chemical reaction that affects the behavior of a gene crucial to the body's defense against pathogens mobilizes immune cells to effectively fight the invaders.
Elizabeth Garrett, the 13th president of Cornell University, heralded a future of greater collaboration at her Sept. 21 introduction to Weill Cornell Medical College.
Two leading organizations are currently funding Dr. Janey Peterson's research on interventions that can help older adults with multiple chronic illnesses become more physically active, thereby improving their health and overall well-being.
A genetic mutation implicated in a common and incurable form of non-Hodgkin lymphoma drives disease development by disrupting the mechanism that manages normal immune cell growth.
